Viewing Study NCT05193292


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2025-12-26 @ 12:58 PM
Study NCT ID: NCT05193292
Status: UNKNOWN
Last Update Posted: 2022-01-14
First Post: 2021-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module